Literature DB >> 2496706

Isoferritins in HIV infection: relation to clinical stage, CD8 lymphocyte binding and the pathogenesis of AIDS.

C Moroz1, S L Misrock, F P Siegal.   

Abstract

Placental isoferritins (PLF), known to be immunosuppressive in Hodgkin's disease and other states, were found to be increased in sera of subjects infected with HIV. We assayed for PLF using a 'sandwich' antigen capture enzyme-linked immunosorbent assay (ELISA) employing two monoclonal antibodies. Individuals with lymphadenopathy, with or without symptoms suggestive of AIDS-related complex, had the highest serum levels, which declined with progressive immunodeficiency. Total (normal) ferritins, in contrast, increased progressively with stage of disease. PLF was found on a subset of CD8 lymphocytes and appeared to block detection of the CD8 antigen by specific monoclonal antibodies. Elution of PLF by incubation with levamisole, but not by culture medium alone, led to the unblocking of the CD8 determinant on these cells. Profiles of isoferritins in HIV infection may provide clues to prognosis. PLF, a physiologic down-regulator of hematopoiesis and cellular immunity, could play a role in the progressive immune deficiency, marrow suppression and HIV expression that lead to AIDS.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2496706

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  9 in total

1.  Placental isoferritin as a physiological downregulator of cellular immunoreactivity during pregnancy.

Authors:  L Sirota; B Kupfer; C Moroz
Journal:  Clin Exp Immunol       Date:  1989-08       Impact factor: 4.330

Review 2.  Practical advice for the gastroenterologist dealing with symptomatic HIV disease.

Authors:  B G Gazzard
Journal:  Gut       Date:  1990-07       Impact factor: 23.059

3.  Elevated serum placental isoferritin in newly diagnosed type 1 (insulin-dependent) diabetes mellitus. A possible marker for identification of high risk subjects.

Authors:  S Assa; C Moroz
Journal:  Diabetologia       Date:  1990-09       Impact factor: 10.122

4.  The immunosuppressive human placental ferritin subunit p43 is produced by activated CD4+ lymphocytes.

Authors:  B Garty; E Kaminsky; C Moroz
Journal:  Clin Diagn Lab Immunol       Date:  1995-03

5.  Placental ferritin in coeliac disease: relation to clinical stage, origin, and possible role in the pathogenesis of malignancy.

Authors:  G Dinari; I Zahavi; H Marcus; C Moroz
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

6.  Hepatic tuberculosis presenting with extreme hyperferritinemia masquerading as adult-onset Still's disease: a case report.

Authors:  Edirisooriya Maddumage Manoj; Rajini Srigrishna; Murugapillai K Ragunathan
Journal:  J Med Case Rep       Date:  2012-07-12

7.  Causes of hyperferritinaemia classified by HIV status in a tertiary-care setting in South Africa.

Authors:  A Visser; C Mostert
Journal:  Epidemiol Infect       Date:  2012-03-15       Impact factor: 4.434

8.  Identification of women with early breast cancer by analysis of p43-positive lymphocytes.

Authors:  L Auerbach; M Hellan; M Stierer; A C Rosen; C Ausch; R Obwegeser; E Kubista; G Wolf; H R Rosen; S Panzer
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

9.  The novel C24D synthetic polypeptide inhibits binding of placenta immunosuppressive ferritin to human T cells and elicits anti-breast cancer immunity in vitro and in vivo.

Authors:  Inna Solodeev; Muayad A Zahalka; Chaya Moroz
Journal:  Neoplasia       Date:  2014-09       Impact factor: 5.715

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.